Alterations of neuronal mitochondria have long been described in the early stages of AD, but several evidence indicate that astrocytic mitochondria are also targeted by molecular hallmarks of AD, such as amyloid beta and amyloid precursor protein (Schmidt et al., 2008; Sarkar et al., 2014). This evidence concerns the gene APP and Alzheimer disease.